Shingles Vaccinations

Patients in the following age groups are eligible for a bulk-billed 2-dose program of the Shingles vaccine once every 5 years:

• Australians aged 65 years and older.
• Individuals aged 19 years and above who have or will have a weakened immune system.

Benefits:

• Convenient access to shingles vaccinations
• Protection against shingles, a painful viral infection caused by the varicella-zoster virus.
• Reduced risk of developing shingles-related complications, such as postherpetic neuralgia.
• Improved quality of life for individuals by preventing shingles-related pain and discomfort.